Pharmafile Logo
Pharmafocus logo
Advanced Search

ABPI

Showing 15 posts of 321 posts found.

EFPIA image

Pharma to disclose doctor payments

July 4, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, pharma, transparency

Pharma companies in Europe will have to reveal how much they pay to doctors under a voluntary agreement set out …

News
Merck Serono image

Merck Serono censured over calls

June 25, 2013
Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA

A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …

News
meaden

New ABPI director of communications announced

June 17, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, Meadden, Whitehead

The ABPI has appointed its head of Policy and Public Affairs Catherine Meaden to be the organisation’s new director of …

Appointment
Leo Pharma image

Leo exaggerates Picato properties

June 14, 2013
Medical Communications, Sales and Marketing ABPI, LEO Pharma, PMCPA

Leo Pharma has been censured by the PMCPA for not maintaining high standards over an advertisement that overreached itself when …

News

ABPI: put more data in scorecards

June 12, 2013
Sales and Marketing ABPI, NHS, scorecards

The ABPI has called on the NHS to include more new medicines in its innovation scorecard and to come up …

News
ABPI image

ABPI declares eye health services ‘unsustainable’

June 11, 2013
Sales and Marketing ABPI, NHS England, POPI, eye health

The ABPI’s Pharmaceutical Ophthalmology Initiative (POPI) group has called for a major re-think in how eye services are delivered on the NHS.The …

News
Goldacre image

Bad pharma, good pharma: an insider’s view

May 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy

Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …

Feature
ABPI image

ABPI takes on vaccine industry brief

May 22, 2013
Research and Development ABPI, vaccines

The ABPI is to take on responsibility for representing the vaccine industry to UK government and healthcare stakeholders.For more than …

News
Pfizer image

Pfizer targets Newcastle

May 15, 2013
Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer

Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …

News
ABPI image

VBP will be ‘unfair’: report

May 8, 2013
Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP

A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …

News

Boehringer’s online PMCPA breach

April 25, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA

Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …

News
abpi_reception

‘No consensus’ on transparency

April 22, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …

News
abpi_reception_close

OHE: drugs spend to rise

April 16, 2013
Medical Communications, Sales and Marketing ABPI, OHE

UK medicines expenditure is set to grow between 3.1% and 4.1% by 2015, according to a study which the researchers …

News

Pharma pays doctors £40m

April 9, 2013
Sales and Marketing ABPI, Bad pharma, ethics

Health professionals received £40 million in payments from pharma companies last year, according to new figures released by the ABPI.This …

News
abpi_reception

Ten pharma firms censured

March 28, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA

Ten pharma companies have been found guilty by the PMCPA of failing to maintain high standards over their involvement in …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026